Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
- Triggering Signals of BRCA1 Breast Cancer (K Kessenbrock)
- Testing Diverse Groups Finds New Breast Cancer Genes (L Teras)
- Black Women & Genetic Testing (J Palmer)
- Women 65+ & Genetic Tests for Breast Cancer Risk (L Teras)
- High-Risk Genes and Screening (A Patel)
- New Risk Calculation May Affect Breast Cancer Screening (L Teras)
- Black Men and Breast Cancer (H Sung)
- Platelets May Help Breast Cancer Spread (E Battinelli)
- Natural Killer Cells & TNBC (R. Chakrabarti)
- Improving Chemotherapy (O Sahin)
- Combo Treatment for TNBC (K Varley)
- Treatments Attack Cell Division (A Holland)
- ER+ Treatment in Mice (P Kenny)
- Blood DNA Monitors Metastasis Treatment (H P Ji)
- PTK6 Gene as Treatment Target (H Irie)
- Time-Lapse Cell Movies (S Spencer)
- 3D Mini Breast Tumors May Help ID New Cancer Treatments
- AI Tool Improves Breast Cancer Prognosis Accuracy
- Exercise & Sitting Time (E. Rees-Punia)
- Cancer Risk Factors in LGBTQ Populations (B. Charlton)
- CPS-3 Disparities Studies
- Cancer Disparities in the US (F. Islami)
- Housing Assistance and Mammograms (H Lee)
- Clinical Trial Treatment Cost App (L Hamel)
- Podcasts, TheoryLab
- Patients Health Insurance Tool (M. Politi)
- Breast Cancer Treatment in Ethiopia (A. Jemal)
- Better Survival Requires Better Insurance (J Zhao)
- Medicaid Eligibility Limits (J Zhao)
- New Treatment for Neuroblastoma (A Heczey)
- Oncogenic Fusions AML (S Meshinchi)
- Genetic Risks (L Teras)
- New Medulloblastoma Drugs (J Rodriguez-Blanco)
- Potential New Hope for MLL (J Grembecka)
- Increase in Brain Tumor Diagnosis (K Miller)
- Longer Life Expectancy for Survivors (J Yeh)
- Potential Target for New Osteosarcoma Drugs (C Benavente)
- At-Home Chemo for Children with HR ALL (L Ranney)
- Childhood Cancer Research Landscape Report
- Tumor-Infiltrating Neutrophils (R. Sumagin)
- New Epigenetic Target (K Rai)
- Extra Chromosomes (Aneuploidy) Effect on Cancer (J. Sheltzer)
- Discovery of a New Biomarker Is the First Step to New Treatment (C. Maher)
- Designer Virus Targets and Kills CRC Cells in Mice (S. Warner)
- Tiny Sensor in Mice May Find Cancer That's Trying to Spread (L. Hao)
- Targeting a Protein “Turned on” by Mistake (N. Gao)
- Spatial Map Intestines (J Hickey)
- CRC Treatment Podcasts
- Keto Molecule & Colorectal Cancer (M Levy)
- Availability of Healthy Food (L Tussing-Humphreys)
- 45 Min/Day of Physical Activity (A Minihan)
- Fewer than 10K Steps/Day (A Patel)
- Yogurt & Cheese & ER- Breast Cancer (M McCullough)
- Stage 2 Clinical Trials for New Endometrial Cancer Drug (V Bae-Jump)
- Hard-to-Starve Pancreatic Cancer Cells (N Kalaany)
- Coffee Risks for Colorectal Cancer (C Um)
- Food Parasite & Brain Cancer Risk (J Hodge)
- Exercise & Quality of Life in Older Survivors (E Rees-Punia)
- 21 Metabolites Linked with Breast Cancer (Y Wang)
- Replacing Sitting May Affect Weight (E Rees-Punia)
- CPS-3 Researchers Ask What People Eat and Check Urine Samples (Y Wang)
- Video Games Motivate Exercise? (E. Lyons)
- Food Choices and Colon Cancer Risk (P. Chandler)
- Race, Exercise & Breast Cancer (C. Dallal)
- Diet with Colorectal Cancer (M. Guinter)
- Biomarkers May Improve Prediction (Y Wang)
- Kickstart NSCLCs Clinical Trials (L. Eichner)
- Mapping Mitochondria's “Dance” (D. Shackleford)
- E-Cig Use Ages 18 to 29 (P. Bandi)
- Stopping Smoking Earlier in Life (F Islami)
- Most with Lung Cancer Smoked (A Jemal)
- Furthering Lung Cancer Screening & Equity (S Fedewa)
- Mouse Lung Organoids for Research (C Kim)
- Quality of Life for Lung Cancer Survivors (J Temel)
- Precision Therapies for NSCLC (P Jänne)
- Cancer Deaths from Smoking (F Islami)
- Lung Cancer Surgery Disparities (A Jemal)
- BRG1-Deficient Lung Cancers (C Kim)
- Yoga for Couples with Lung Cancer (K Milbury)
- Metabolic Differences as New Drug Targets (A Marcus)
- CPS-II & CPS-3 Inform About Risks of Ovarian Cancer
- Machine Learning & Glowing Nanosensors (D Heller)
- Ovarian Cancer May Start in Fallopian Tube Cells (K Lawrenson)
- New Gene Linked with Deadliest Type (C Han)
- Gene-Testing Tools May Personalize Care (A Sood)
- Chromosome-Hoarding Ovarian Cancer Cells & Treatment (J Sheltzer)
- Nanoparticles as Drug Delivery for Metastases (X Lu)
- Turning Off 2 Proteins to Slow HGSC (P Kreeger)
- Targeted Light Therapy in Mice (M Bai)
- Nanoparticles, CAR T, and CRISPR (M Stephan)
- Endometriosis & Ovarian Cancer in Mice (M Wilson)
- Ovarian Cancer Special Section
- UV Exposure, Melanoma, & Dark Skin Types (A. Adamson)
- Melanoma and Lipid Droplets (R. White)
- Zebrafish and Acral Melanoma (R. White)
- T-Cell Lymphoma and PD1 (J. Choi)
- New Drug Destroys Cancer-Causing Protein (C. Crews)
- Virus & Merkel Cell Skin Cancer (R. Wang)
- Non-Genetic Drug Resistance (S. Spencer)
- Hijacking the Body's Sugar (R. Wang)
- Telling about High Risk (P. Kanetsky)
- Brain Metastasis and Alzheimer’s (E. Hernando)
- Exhausted Melanoma "Killer" Cells (W. Cui)
When More People Qualify for Medicaid, More Survive Cancer
Researchers found that people didn’t live as long after a cancer diagnosis when they lived in states that limit Medicaid to only those with very low incomes.
The Challenge
The Medicaid program provides health insurance coverage in the United States for some people with limited incomes, families and children, pregnant women, the elderly, and people with disabilities. It’s jointly funded by federal and state governments. But each state has the ability to set the maximum amount of money a family can make a year and still qualify for Medicaid. This maximum is often referred to as the Medicaid income eligibility limit.
What Does 138% FPL Mean?
FPL stands for Federal Poverty Line. It’s published each year by the US Department of Health and Human Services and used to set eligibility limits for several programs and benefits. These programs include Medicaid, Children’s Health Insurance Program (CHIP), Supplemental Nutrition Assistance Program (SNAP), Supplemental Nutrition Program for Women, Infants, and Children (WIC), and other “welfare” programs.
138% FPL is the maximum yearly income the ACA supports for people to qualify for Medicaid. In 2022 for example, the FPL for a family of 3 is $23,030. The ACA provides financial incentives that allow parents in a family of 3 to have a yearly income up to 138% of the FPL, which is $31,781 [$23,030 + (38% of $23,030)], and still qualify for Medicaid. 37 states have 138% FPL as their Medicaid income eligibility limit.
But states can set their own income limits for Medicaid eligibility, and they can be below, at, or above the FPL.
At 221% of the FPL, Washington D.C. has the most generous Medicaid income eligibility limitfor a family of 3 in 2022. That’s equal to $50,896 a year. Connecticut’s limit is 160% FPL, and it’s the only other state to have a high income limit, above 138% FPL.
At 16% of the FPL, Texas has the least generous Medicaid income eligibility limit for a family of 3 in 2022. That’s $3,684 a year. That means that families of 3 who make more $3,684 a year, even if they still fall below the poverty line, do not qualify for health insurance through Medicaid.
Since 2014, the Affordable Care Act (ACA) provided financial incentives to states to increase the number of people who would be eligible to receive Medicaid. But not all states have accepted the offer and expanded Medicaid.
States that only allow people who have very low yearly incomes to be able to receive Medicaid benefits may keep many people who live in that state from having health insurance. And research has shown that people who don’t have health insurance often do not receive cancer care. They’re less likely to get screened, be diagnosed with cancer when it’s at an early stage and less complicated to treat, and to receive guideline-based cancer treatment and survivorship care.
Little research has been done to examine how Medicaid qualification based on a maximum income limit before the ACA affected cancer outcomes. Learning more could inform policies related to income maximums for Medicaid eligibility.
The Research
American Cancer Society (ACS) researcher Jingxuan Zhao, MPH, and some of her colleagues in Surveillance & Health Equity Science recently published their study about how state historic income eligibility limits for Medicaid affect long-term survival among people newly diagnosed with cancer.
We consistently found a link between lower Medicaid eligibility limits and worse survival after a cancer diagnosis. And that was true whether the cancer was found at an early or late stage. Our findings show that Medicaid plays an important role in improving health outcomes for people diagnosed with cancer that could be explained for multiple reasons.”
Jingxuan Zhao, MPH
Senior Associate Scientist
Health Services Research
“Having health insurance may improve access to timely, may make receiving guideline-based treatment easier to receive and complete, and may improve access to specialized healthcare in survivorship, psychosocial care, and end-of-life care and hospice care,” Zhao says.
They used data from the National Cancer Database to identify people who were:
- Diagnosed with 1 of 19 common types of cancer during the years 2010 to 2013, which was before the ACA was in effect
- From all states
- Ages 18 to 64 years old
About 1.5 million individuals newly diagnosed with cancer were included in the study. Survival time was measured from the diagnosis date to the end of the study for up to 8 years of follow-up. And the researchers categorized states’ Medicaid income eligibility limits as: 50% FPL or less, 51% to 137% FPL, and 138% FPL or more.
They found that people with cancer living in states with lower Medicaid income eligibility limits did not live as long after a diagnosis for most types of cancer (both early and late stage), compared to those living in states with higher Medicaid income eligibility limits, set at 138% FPL or above.
The researchers note that future studies that focus on the link between Medicaid income eligibility limits and access to specific cancer treatments and cancer survivorship care are needed.
Why It Matters
Results of this nationwide study suggest that national or state policies, or both, that raise the income eligibility limits for Medicaid may improve survival after a cancer diagnosis in the US.